Yashashwi Pokharel is a Cardiology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston Salem, NC 271573220
Telephone
336-716-2255Provider last certified this registry record 24 Nov 2020.
Clinical trials
- Tailoring TM-HTN Intervention for Black Patients
Sponsor: Wake Forest University Health Sciences
- Team Based Equity Conscious Telemedicine Approach to Hypertension
Sponsor: Wake Forest University Health Sciences
- Telemedicine Management of Hypertension
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92.3%Beta blocker26.3%Metoprolol Succinate51%Carvedilol43%Metoprolol Tartrate7%Part D<11 patientsStatin18.9%Rosuvastatin Calcium76%Atorvastatin Calcium24%Part D≥82 patients+ 10 more classes in this area
Blood & clotting
4.9%Factor Xa inhibitor4.9%Eliquis100%Part D≥25 patientsMetabolism & gastrointestinal
2.8%Proton pump inhibitor1.1%Pantoprazole Sodium100%Part D<11 patientsSGLT2 inhibitor0.9%Jardiance100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Tailoring a Telemedicine Hypertension Management Intervention for Patients with High Social Needs or Social Risk Factors
Wake Forest University Health Sciences
FY2025$155,987K23HL171954 - Tailoring a Telemedicine Hypertension Management Intervention for Black Patients
Wake Forest University Health Sciences
FY2024$156,576K23HL171954
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”